PatientsVille.com Logo

PULMONARY EMBOLISM and Methadone

PatientsVille

PULMONARY EMBOLISM Symptoms and Causes

A pulmonary embolism is a sudden blockage in a lung artery. The cause is usually a blood clot in the leg called a deep vein thrombosis that breaks loose and travels through the bloodstream to the lung. Pulmonary embolism is a serious condition that can cause

  • Permanent damage to the affected lung
  • Low oxygen levels in your blood
  • Damage to other organs in your body from not getting enough oxygen

If a clot is large, or if there are many clots, pulmonary embolism can cause death.

Half the people who have pulmonary embolism have no symptoms. If you do have symptoms, they can include shortness of breath, chest pain or coughing up blood. Symptoms of a blood clot include warmth, swelling, pain, tenderness and redness of the leg. The goal of treatment is to break up clots and help keep other clots from forming.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for PULMONARY EMBOLISM

PULMONARY EMBOLISM treatment research studies

Methadone clinical trials, surveys and public health registries


Find Drug Side Effect reports



Methadone Side Effects

Toxicity To Various Agents (601)
Cardiac Arrest (334)
Respiratory Arrest (316)
Completed Suicide (256)
Overdose (197)
Death (147)
Electrocardiogram Qt Prolonged (142)
Torsade De Pointes (97)
Respiratory Depression (82)
Cardio-respiratory Arrest (73)
Somnolence (65)
Accidental Overdose (59)
Nausea (57)
Pulmonary Oedema (57)
Loss Of Consciousness (54)
Vomiting (51)
Confusional State (47)
Pneumonia (40)
Dyspnoea (39)
Syncope (39)
Mental Status Changes (38)
Pain (37)
Fall (37)
Sedation (36)
Bronchopneumonia (36)
Dizziness (35)
Hypotension (31)
Convulsion (31)
Hyperhidrosis (31)
Malaise (30)
Depressed Level Of Consciousness (30)
Coma (29)
Unresponsive To Stimuli (27)
Intentional Overdose (27)
Constipation (27)
Feeling Abnormal (26)
Hypokalaemia (26)
Pulmonary Congestion (26)
Renal Failure Acute (26)
Ventricular Tachycardia (25)
Headache (25)
Fatigue (25)
Brain Oedema (25)
Lethargy (24)
Rhabdomyolysis (24)
Respiratory Failure (24)
Incorrect Dose Administered (23)
Bradycardia (23)
Accidental Poisoning (23)
Miosis (22)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

I was having frequent leg cramps. They worked their way from my foot up to my thigh. I just thought it was from stopping the use of muscle relaxers ( for a serious back and neck problem). I had forgotten about them and never mentioned it to either

Good afternoon doc,my name dimasautisme,i comefrom indonesia ? im methadoners with 120 mg,im drink ARV to?please private my status? i just want quesstion i want to detox,where i must go to hospital doc? please help me :-D :)

I have been on methadone for two years. Went fro 70 mgs a day to 20. I do for pain and I have been prescribed klonipin also recently for severe panic attacks and I read online that it's a deadly combo. I take my methadone at 9 am. And have panic

In Oct. 2009 I went to the Emergency Room of my local hospital for a shortness of breath as I was struggling to catch my breath. I was asked if I had chest pain and responded no, just difficulty breathing. I was given morphine, pr

Ive been takeing 90mls of methadone for approxamitley 2 years on and off but properly this time for a total off 7 months i get servere sweating from taking my methadone and feel very hot like im burning up and dripping with sweat why is this happenin

Methodone Side Effects, I have had many trips to Emergency Unit at my Town, having tight painful heart problems. But when they do the Tests for Heart attacks, I jave always been told I have no problem my heart is fine. I have had ECG Tests, all fine.

My father died suddenly of a pulmonary Embolism with no signs or symtoms. We are devasted.....but the one thing that keeps pulling on my heart strings is he was already on blood thinners for years after his quadrapal by pass 13 years ago. He has been

On the 12th dec2011 i nearly died from a p. e. that had been going on for some time.I had a saddle on my lungs.I was 10 days in hospital & was treated with continued oxygen,clexane injections,warfaring pills,paracetamol pills,antibiotics in

What's on your mind...I am two months post PE after a total knee revision. Then three bleeds into the knee (big hematoma). Week later bleed and fluid into an already bad right shoulder requiring hospitalization. I am improving, however sleep an ext

My father is suffrering from idiotypic Pulmonary Fibrosis. In medication he is taking Prednisone,Perfenodone and azathropine. he is now geeting bleeding from his nose.Can anybody inform me that this is just a side effect of any d

After a pulmunary embolism diagnosis in April 2010, I was put on Warfarin for 11 months ... I was taken off it 1 week ago... While on it I experienced extreme lethargy , difficulty concentrating, memory loss, dizziness, ongoing ch

After being discharged from eER I saw in my file that the doppler impression shows mild tricuspid regurgitation and mild pulmonary hypertension =-O scared should I be worried

Completed course of interferon and ribavirn for Hepititis C. Fell pregnant 5 months after completion of treatment and gave birth to a baby boy weighing 7.6 lbs. He has Trisomy 21. He was born with Persisitant Pulmonary hypertension and a VSD. I do no

Female 39 years old from Denmark. Was treated with Octostim as a test. After drug was administred i experience this: <span style='font-weight: bold;'><a href='http://sideeffects101.com/drug-side-effects/o/octostim-pulmonary-oedema.htm' rel='

Has any one found legal representation willing to pursue pulmonary embolis caused by avandia

Having suffered 3 dvt's, 1 pulmonary embolism, 1 stroke and 2 tis's, I was given Fragmin. I previously had been taking warfarin for about 20 yrs, this ceased to work. I am now told that I have Osteoporosis... I seem to remember along the way that

Hello, im using trabectedin in a few weeks, after using ifoosfamide+doxorrubicin to treat pulmonary methastasis or a synovial sarcoma i am concened about loosin my hair again because it means too much for a woman and is not easy to use a wig in summ

How long can one live with the diagnosis of pulmonary hypertension? I have seen 3 to 5 years but I have had it for well over 10.

Husband has been taking avodart for 3 years. Developed a tightness in lungs, dry, non-productive cough, lungs feel a burning sensation. Thorough heart echo tests done, stress test. chest x-ray, mri, blood work, pulmonary function tests all passed.

PULMONARY EMBOLISM Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting The Use of Methadone in Newborn Infants
Conditions: Premature Birth of Newborn;   Critically Ill
Intervention: Drug: Methadone
Outcome Measures: Methadone PK and EDDP;   DNA
2 Recruiting Methadone in Pediatric Anesthesiology II
Condition: Pain
Interventions: Drug: Group 1- 0.4mg/kg IV Methadone HCl;   Drug: Group 2 - 0.5mg/kg IV methadon HCI;   Other: Group 3 - control no Methadone
Outcome Measures: Morphine consumption;   Pain scores;   Methadone clearance
3 Recruiting CYP2B6 Polymorphisms in Methadone
Condition: Healthy Volunteers
Interventions: Drug: racemic Methadone HC1;   Drug: Oral deuterated racemic Methadone HCl,
Outcome Measures: The effects of Methadone on healthy volunteers;   Methadone and bupropion concentration;   Methadone and bupropion clearance from the body;   Oral Methadone and bupropion absorption;   Influence of CYP2B6*6 hetero or homozyge genotype on the above primary and secondary outcomes
4 Unknown  Compare Methadone Combined With N-Acetyl-Cysteine (NAC) and Methadone Alone for Opioids Astaining
Condition: Opioids Use
Interventions: Drug: Methadone; NAC;   Drug: Methadone
Outcome Measure:
5 Recruiting Treatment of Pain in Head-and-Neck Cancer Patients: is Methadone More Effective?
Conditions: Pain;   Cancer of Head and Neck
Interventions: Drug: fentanyl;   Drug: Methadone
Outcome Measures: significant pain relief (reduction of Numeric Rating Scale (NRS) of 50%);   time to achieve significant pain relief;   side-effect profile
6 Recruiting Methadone vs Magnesium in Spinal Fusion
Condition: Idiopathic Scoliosis
Interventions: Drug: Methadone hydrochloride;   Drug: Magnesium Sulfate;   Drug: Remifentanil
Outcome Measures: Intra- and Post-operative Pain Relief;   Intra-operative parameters
7 Not yet recruiting Drug Interaction & Methadone & Buprenorphine
Condition: Hepatitis C
Interventions: Drug: Methadone;   Drug: DCV 3DAA FDC;   Drug: BMS-791325;   Drug: Buprenorphine;   Drug: Naloxone
Outcome Measures: Maximum observed concentration (Cmax) of R-Methadone for Part 1;   Area under the concentration-time curve in one dosing interval (AUC(TAU)) of R-Methadone for Part 1;   Cmax of Buprenorphine and Norbuprenorphine for Part 2;   AUC(TAU) of Buprenorphine and Norbuprenorphine for Part 2;   Cmax of S-Methadone and Total Methadone for Part 1;   AUC(TAU) of S-Methadone and Total Methadone for Part 1;   Concentration at 24 hours (C24) of S-Methadone, Total Methadone and R-Methadone for Part 1;   Time of maximum observed concentration (Tmax) of S-Methadone, Total Methadone and R-Methadone for Part 1;   C24 of Buprenorphine and Norbuprenorphine for Part 2;   Tmax of Buprenorphine and Norbuprenorphine for Part 2;   Ratio of metabolite AUC(TAU) to parent AUC(TAU) (MR_AUC(TAU)) of Norbuprenorphine to Buprenorphine;   Cmax of of Daclatasvir (DCV) , Asunaprevir (ASV) , BMS-791325, and BMS-794712;   AUC(TAU) of DCV, ASV, BMS-791325, and BMS-794712;   Concentration at 12 hours (C12) of DCV, ASV, BMS-791325, and BMS-794712;   Tmax of DCV, ASV, BMS-791325, and BMS-794712;   MR_AUC(TAU) for BMS-794712 to BMS-791325;   Incidence of Adverse Events (AEs), Serious Adverse Events (SAEs), death and AEs leading to discontinuation;   Results of vital signs, Electrocardiograms (ECGs), Physical Examinations (PEs) and clinical labs;   Scores of Clinical Opiate Withdrawal Scale (COWS), Subjective Opiate Withdrawal Scale (SOWS), Objective Opiate Withdrawal Scale (OOWS), and Opiate Overdose Assessment (OOA)
8 Recruiting Pharmacokinetics of Multiple Dose Methadone in Children Treated for Opiate Withdrawal
Condition: Opiate Withdrawal Syndrome
Intervention: Drug: Methadone
Outcome Measures: PK Parameters after multiple doses of enteral Methadone;   PK of Methadone's primary metabolite EDDP;   PK of R- and S-enantiomers of Methadone;   Correlation between plasma and DBS samples;   Correlation between plasma and scavenge samples;   Influence of CYP3A4 and CYP3B6 genetic polymorphisms on Methadone PK;   Methadone pharmacodynamics using the WAT-1;   Adverse events
9 Unknown  Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone
Conditions: Post Operative Pain;   Hyperalgesia
Interventions: Drug: ketamine infusion;   Drug: Methadone PCA
Outcome Measures: the extent of hyperalgesia area proximal to surgical wound;   pain intensity;   opioids related adverse events
10 Unknown  Methadone Versus Morphine for Orthopedic Surgery Patients
Conditions: Fracture;   Pain, Postoperative
Interventions: Drug: Methadone;   Drug: Morphine
Outcome Measures: Opioid consumption during the 48 hours after surgery;   Time to initial dose of rescue analgesic;   Overall rescue analgesic;   Side effects with special attention paid to respiratory rate and possible respiratory depression, and PONV;   Overall satisfaction of the patient with the analgesic graded on a scale of 1-5
11 Recruiting Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids.
Condition: Pain Related to Cancer
Intervention: Drug: Methadone
Outcome Measure: Binary main criterion based on success/failure rate related to Methadone switch on Day 4.
12 Unknown  Efficacy of Drug and Risk Counseling Among Methadone Patients in Jakarta, Indonesia
Conditions: HIV Risk Behaviors;   Heroin Injection;   Retention in Methadone Treatment
Interventions: Behavioral: Behavioral Drug and Risk Counseling (BDRC);   Behavioral: Methadone maintenance treatment
Outcome Measures: Injection drug use;   retention in Methadone treatment
13 Unknown  Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone
Condition: Substance-Related Disorders
Interventions: Drug: midazolam(drug), digoxin (drug);   Drug: Bupropion (drug);   Drug: Methadone (drug)
Outcome Measures: Explore if there is a correlation between the areas of the concentration curves of probe substrates for CYP3A4 and/or CYP2B6 and Pgp and the area of the concentration curve of Methadone.;   LC-MS assays will be developed to analyze the plasma content of the probe substrates, Methadone and their metabolites. Specifically, midazolam, 1-OH midazolam, bupropion, t-butyl-hydroxy bupropion, digoxin, Methadone, and EDDP (a Methadone metabolite).;   Isolate and bank the DNA of the subjects for future genotyping of variant alleles that will be identified in this study to be important in Methadone pharmacokinetics.
14 Recruiting Efficacy Methadone for Management Postoperative Pain After the Use of Anesthesia Intravenous in Laparoscopic Cholecystectomy
Condition: Pain, Postoperative
Interventions: Drug: Morphine;   Drug: Methadone;   Drug: TIVA
Outcome Measures: Difference in milligrams of morphine used as rescue analgesia;   Difference in pain scores, using the Numeric Rating Scale
15 Not yet recruiting Pilot Study of Nicotine Nasal Spray and Varenicline on Smoking in Methadone-Maintained Patients
Conditions: Cigarette Smoking;   Methadone Maintenance
Interventions: Drug: Nicotine Nasal Spray;   Drug: Varenicline;   Drug: Placebo Nasal Spray;   Drug: Placebo Varenicline
Outcome Measures: Proportion of daily cigarettes smoked in the 4 hours after receiving Methadone dose;   Cigarettes per day;   Carbon monoxide level
16 Recruiting Pupillometry and Pain Thresholds Patients Substituted by Methadone and Buprenorphine
Conditions: Opiate Dependent;   Previous Illicit Drug Use
Intervention: Drug: Buprenorphine and Methadone Hydrochloride
Outcome Measures: Measurement of the pupil diameter;   - The mechanical punctuate pain threshold as measured by Electronical Von Frey;   - The mechanical pressure pain threshold measured by Algometer on the tibial bone;   - The pupil diameter measured in scotopic .conditions (via infrared camera) at the hypothetical peak effect of either Methadone or buprenorphine.;   - The pupil diameter measured in photopic conditions (via infrared camera) at the hypothetical residual effect of either Methadone or buprenorphine
17 Recruiting Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients
Condition: Low Back Pain
Interventions: Drug: Methadone;   Drug: Buprenorphine/naloxone
Outcome Measures: Analgesia;   Illicit drug use;   Cravings;   Functioning;   Depression;   Treatment retention
18 Recruiting Conversion From Parenteral to Oral Methadone.
Condition: Pain
Interventions: Drug: Parenteral /oral Methadone ratio 1:2;   Drug: Parenteral /oral Methadone ratio 1:1.2
Outcome Measures: Proportion of intoxicated patients in each groups;   Parenteral/oral MTD final ratio in patients considered as "failure"
19 Recruiting Methadone in Pediatric and Adult Sickle Cell Patients
Condition: Sickle Cell Disease
Interventions: Drug: Morphine;   Drug: Methadone
Outcome Measures: To determine the pharmacokinetics of Methadone in children and adults with Sickle Cell disease experiencing a VOE.;   Pain
20 Unknown  Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain
Conditions: Cancer;   Pain;   Palliative Care
Intervention: Drug: Methadone plus Acetaminophen or Placebo
Outcome Measures: Pain intensity and time to equianalgesic effect;   Degree of nausea, vomiting, obstipation, xerostomia and drowsiness